Negishi Kazuno

Sleep Disorders are a Prevalent and Serious Comorbidity in Dry Eye.

Possible explanations for sleep disorders in DED may be depression, pain, and eye exposure at night.

Topical Application of Bunazosin Hydrochloride Suppresses Myopia Progression With an Increase in Choroidal Blood Perfusion.

These results demonstrate the potential of BH eye drops in the treatment of myopia and support further investigation of their efficacy in humans.

Long-term Alcohol Consumption and Risk of Exfoliation Glaucoma or Glaucoma Suspect Status among United States Health Professionals.

Long-term alcohol consumption was associated with a higher risk of XFG/XFGS status. Our findings provide further clues regarding the XFG/XFGS etiology.

Symptomatic Presbyopia may Develop Earlier in Patients With Glaucoma-A Cross-Sectional Retrospective Cohort Study.

Glaucoma patients treated with eye drops may start near correction earlier.

Ten-year outcomes of congenital cataract surgery performed within the first six months of life.

In patients with genuine congenital cataract, surgery within the critical period of visual development results in better final visual acuity, albeit with an increased risk of visual axis opacification.

Association Between Glycemic Traits and Primary Open-Angle Glaucoma: A Mendelian Randomization Study in the Japanese Population.

We did not observe strong evidence to support the association between genetically predicted glycemic traits and POAG in the Japanese population.

Presbyopia Progression From the Age of 40 to 79 Years in Glaucoma Patients Treated With Prostaglandin F Receptor Agonists.

There was an earlier progression of presbyopia determined by near add power in glaucoma patients treated with FP receptor agonists compared with controls.

Metabolomic Profiling of Open-Angle Glaucoma Etiologic Endotypes: Tohoku Multi-Omics Glaucoma Study.

Integrated metabolomic profiles identified five distinct etiologic endotypes of OAG, suggesting pathological mechanisms related with a high-risk group of central vision loss progression in the Japanese population.

Nicotinamide mononucleotide, a potential future treatment in ocular diseases.

Our current review suggests and discusses new modes of actions of NMN for the prevention of and protection from various ocular diseases and can urge future research to obtain more solid evidence on a potential…